Targeting ‘undruggable’ proteins: Frontier collaborates with AbbVie

Frontier and its chemoproteomics platform are aiming to overcome the challenges faced in traditional small molecule drug discovery and development. Credit: FRED TANNEAU/AFP via Getty Images